SCHEMBL8102988

SCHEMBL8102988

CN(C)CCOC(=O)CCCCC(S)CCS

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.58
CHRM1 P11229 2/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRM3 P20309 1/20 0.40
CHRNA4 P43681 1/20 0.40
DGKA P23743 1/20 0.39
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
GAA P10253 1/20 0.35
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16312502 0.84 DGKA (0.43) DNM1DGKAALDH1A1CYP3A4L3MBTL1
SCHEMBL16374096 0.83 DGKA (0.43) DNM1DGKAALDH1A1CYP3A4L3MBTL1
SCHEMBL8095315 0.83 DGKA (0.51) DNM1DGKAALDH1A1CYP3A4TSHR
SCHEMBL1333132 0.82 DNM1 (0.81) DNM1CHRM1CHRM2CHRM4CHRM5
SCHEMBL2580673 0.81 CYP1A2 (0.47) DNM1DGKAALDH1A1CYP3A4CYP1A2
SCHEMBL9315300 0.81 DGKA (0.57) DNM1DGKAALDH1A1TSHRMAPT
SCHEMBL16480294 0.81 DGKA (0.45) DNM1DGKAALDH1A1CYP3A4CYP1A2
SCHEMBL10385363 0.80 DNM1 (0.85) DNM1CHRM1CHRM2CHRM4CHRM5
SCHEMBL2580934 0.80 CYP1A2 (0.46) DNM1DGKAALDH1A1CYP3A4CYP1A2
SCHEMBL8906649 0.78 THRB (0.41) DNM1DGKAALDH1A1CYP3A4BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed